Health Condition 1: C690- Malignant neoplasm of conjunctiva
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged more than 18 years with a clinical diagnosis of ocular surface squamous neoplasia confirmed on cytology or biopsy Patients who are planned for surgical excision of OSSN and agree to study participation and follow up
Exclusion criteria
Exclusion criteria: Intraocular or orbital OSSN (AJC stage T 3 O R T4)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumour response to treatment (Slit-lamp biomicroscopy, ASOCT, Impression cytology), recurrence or relapse, side effects and correlation of iOCT findings with histopathological reports will be noted in follow-up Timepoint: 1 month, 2 months, 3 months, 4 months post-operatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Dr. Rajendra Prasad Centre for Ophthalmic Sciences All India Institute of Medical Sciences (AIIMS)